GLP 1 Gansemer

Dr. Nicole Gansemer, Naturopathic Physician Dr. Nicole Gansemer, ND | Hawthorn Healing Arts

GLP-1 medications are most often talked about as weight-loss drugs. While weight changes can be helpful for some people, this narrow focus misses the much bigger picture, especially for patients living with complex, chronic health conditions such as mast cell activation syndrome (MCAS), mold illness, chronic digestive issues, blood sugar problems, and ongoing inflammation.¹

In functional and naturopathic medicine, we don’t just look at symptoms. We look at what is driving them. That means paying attention to how the immune system, metabolism, nervous system, gut, and environmental exposures all interact. When viewed this way, GLP-1 medications may offer benefits that go well beyond the number on the scale.

Below are some of the ways GLP-1 medications may support healing in people with complex chronic illness.

Calming Inflammation and the Immune System

GLP-1 receptors are found on many immune cells, including mast cells.²,³ These medications appear to help calm an overactive immune system by reducing inflammatory signals that keep the body stuck in a constant “on” state.

In conditions like MCAS, mast cells release histamine and other chemicals too easily, triggering symptoms across many body systems. Early research and clinical experience suggest that GLP-1 medications may help mast cells behave more calmly, reducing the release of these inflammatory substances.²,³ For patients, this may translate into fewer flares, less overall inflammation, and improved symptom stability.

Supporting Blood Sugar Balance and Energy

Many people with chronic illness struggle with unstable blood sugar even if they are not overweight. Inflammation, infections, stress, and mold exposure can all interfere with how the body handles sugar.

GLP-1 medications help by:

  • Supporting steadier blood sugar levels
  • Reducing sharp spikes after meals
  • Improving how the body uses insulin
  • Supporting healthier fat metabolism⁵

When blood sugar is more stable, the body experiences less stress. This can lead to more consistent energy, fewer crashes, reduced cravings, and less inflammation overall.

Brain Health and the Gut–Brain Connection

GLP-1 receptors are also found in the brain, including areas involved in focus, mood, appetite, and the nervous system. Research suggests these medications may help reduce inflammation in the brain and support healthier brain signaling.⁶

Many patients report benefits such as:

  • Clearer thinking and less brain fog
  • Improved focus
  • Fewer compulsive food thoughts
  • Improved mood stability

Importantly, these changes often happen before any significant weight loss, suggesting the benefits go far beyond appetite control.⁶

Mast Cell Stability and Histamine Symptoms (Emerging Evidence)

Mast cells do more than release histamine, they communicate with many other immune cells and help regulate inflammation throughout the body.⁷ New research suggests that mast cells have GLP-1 receptors, meaning these medications may directly influence how reactive mast cells are.²

In a 2025 case series of patients with difficult-to-treat MCAS, nearly 90% experienced meaningful improvement in symptoms after starting a GLP-1 medication.² While more research is needed, this is a promising signal.

Gut Function, Fullness, and Microbiome Support

GLP-1 medications slow digestion and help people feel full sooner. While this is often described as a side effect, for many patients it can actually be helpful.

These effects may:

  • Reduce blood sugar swings after meals
  • Improve digestive comfort
  • Decrease inflammatory food reactions
  • Support more mindful eating⁵

GLP-1 also affects the gut lining and immune system in the digestive tract, which may help calm gut inflammation and support a healthier gut environment. This is especially important for those with chronic digestive symptoms.⁸

Reducing “Food Noise” and Stress on the Body

Living with chronic illness is stressful. Constant blood sugar swings and hunger signals can keep the nervous system in a heightened stress state.

Many patients describe GLP-1 medications as turning down “food noise”. When this signal quiets, the body often feels calmer. This may support better sleep, lower stress hormones, and improved nervous system balance.⁶

A Tool, Not a Standalone Solution

GLP-1 medications are not a cure, and they are not right for everyone. They work best as one piece of a personalized treatment plan that also addresses:

  • Chronic infections and immune imbalance
  • Mold and environmental toxin exposure
  • Nutrient deficiencies
  • Gut health
  • Nervous system regulation

When used thoughtfully and monitored carefully, GLP-1 medications may help lower the overall inflammatory and metabolic burden, allowing the body to heal more effectively.

For patients with complex chronic illness, the real question isn’t “Will this help me lose weight?” It’s “Will this help calm inflammation, stabilize my system, and support long-term healing?”

When viewed through this broader lens, GLP-1 medications become a promising option worth thoughtful discussion. If you’re wondering whether this type of medication might be appropriate for your health picture, it’s a conversation best had within a personalized, root-cause-focused care model.

Appointments with Dr. Gansemer are available by calling 541-330-0334, email [email protected] or visit our online request form.

References

  1. Wilbon SS, Kolonin MG. GLP-1 receptor agonists—effects beyond obesity and diabetes. Cells. 2024;13(1):65.
  2. Wong CK, Drucker DJ. Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits. J Clin Invest. 2025;135(21):e194751. Published 2025 Nov 3.
  3. Wong CK, McLean BA, Baggio LL, et al. Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation. Cell Metab. 2024;36(1):130-143.e5.
  4. Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27(4):740-756.
  5. Afrin LB, Weinstock LB, Dempsey TT, Aschenbrenner K, Blitshteyn S, Schofield JR. Utility of glucagon-like-peptide-1-receptor agonists in mast cell activation syndrome. Am J Med Sci. 2025;370(4):377-382.
  6. Thiara D. Glucagon-like peptide-1 receptor agonists: emerging neuroprotective potential. JAMA Neurol. 2025;82(1):9-11.
  7. Hölscher C. Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases. Trends Mol Med. 2014;20(10):543-552.
  8. Athauda D, Foltynie T. Protective effects of GLP-1 receptor agonists in neurodegenerative disease. Nat Rev Neurol. 2016;12(6):351-362.
  9. Thin L, Teh WL. GLP-1 receptor agonists and immune-mediated inflammatory disease: emerging therapeutic potential. Biomedicines. 2025;13(5):1128.

Neurath MF, et al. GLP-1 receptor signaling in intestinal inflammation and immune regulation. J Crohns Colitis. 2025;19(9):jjaf167.